Skip to main content
OpenTrials

Clinical trial condition

Poxviridae Infections

Explore clinical trials studying Poxviridae Infections. Study availability and eligibility vary by location and protocol.

164 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Poxviridae Infections trial results

Completed

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Orlando Clinical Research Center Orlando, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kentucky, School of Medicine, Department of Medicine Lexington, Kentucky, United States
  • University of Rochester, Medical Center Rochester, New York, United States
View Trial Details
Completed

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

NCT00316602

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, +14 more
Locations
  • Alta Clinical Research LLC Tucson, Arizona, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Rx Clinical Research, Inc. Garden Grove, California, United States
  • Solano Clinical Research Vallejo, California, United States
View all 22 locations
View Trial Details
Completed

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

NCT01144637

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • National Research Institute Los Angeles, California, United States
  • Northern California Clinical Research Center (NCCRC) Redding, California, United States
View all 34 locations
View Trial Details
Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

NCT02474589

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Coastal Clinical Research, Inc. Mobile, Alabama, United States
  • Paradigm Research Redding, California, United States
  • Paradigm Research San Diego, California, United States
  • Johnson County Clinical Trials Lenexa, Kansas, United States
View Trial Details
Completed

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

NCT01827371

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland Medical System - General Clinical Research Center (GCRC) Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details

Related conditions